Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Treatment of latent tuberculosis with 12-weeks isoniazid/rifapentine in clinical practice.

Fröberg G, Jansson L, Bruchfeld J.

Eur Respir J. 2018 Nov 8. pii: 1801128. doi: 10.1183/13993003.01128-2018. [Epub ahead of print] No abstract available.

PMID:
30409821
2.

Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013.

Morris U, Xu W, Msellem MI, Schwartz A, Abass A, Shakely D, Cook J, Bhattarai A, Petzold M, Greenhouse B, Ali AS, Björkman A, Fröberg G, Mårtensson A.

Infect Genet Evol. 2015 Jul;33:110-7. doi: 10.1016/j.meegid.2015.04.018. Epub 2015 Apr 24.

PMID:
25917493
3.

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.

Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, Price RN, Mårtensson A, Rosenthal PJ, Dorsey G, Sutherland CJ, Guérin P, Davis TM, Ménard D, Adam I, Ademowo G, Arze C, Baliraine FN, Berens-Riha N, Björkman A, Borrmann S, Checchi F, Desai M, Dhorda M, Djimdé AA, El-Sayed BB, Eshetu T, Eyase F, Falade C, Faucher JF, Fröberg G, Grivoyannis A, Hamour S, Houzé S, Johnson J, Kamugisha E, Kariuki S, Kiechel JR, Kironde F, Kofoed PE, LeBras J, Malmberg M, Mwai L, Ngasala B, Nosten F, Nsobya SL, Nzila A, Oguike M, Otienoburu SD, Ogutu B, Ouédraogo JB, Piola P, Rombo L, Schramm B, Somé AF, Thwing J, Ursing J, Wong RP, Zeynudin A, Zongo I, Plowe CV, Sibley CH; ASAQ Molecular Marker Study Group; WWARN AL.

Am J Trop Med Hyg. 2014 Oct;91(4):833-43. doi: 10.4269/ajtmh.14-0031. Epub 2014 Jul 21. Erratum in: Am J Trop Med Hyg. 2015 May;92(5):1084.

4.

Assessing the cost-benefit effect of a Plasmodium falciparum drug resistance mutation on parasite growth in vitro.

Fröberg G, Ferreira PE, Mårtensson A, Ali A, Björkman A, Gil JP.

Antimicrob Agents Chemother. 2013 Feb;57(2):887-92. doi: 10.1128/AAC.00950-12. Epub 2012 Dec 3.

5.

CYP2C8 status of patients with malaria influences selection of Plasmodium falciparum pfmdr1 alleles after amodiaquine-artesunate treatment.

Cavaco I, Mårtensson A, Fröberg G, Msellem M, Björkman A, Gil JP.

J Infect Dis. 2013 Feb 15;207(4):687-8. doi: 10.1093/infdis/jis736. Epub 2012 Nov 30. No abstract available.

PMID:
23204183
6.

Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar.

Fröberg G, Jörnhagen L, Morris U, Shakely D, Msellem MI, Gil JP, Björkman A, Mårtensson A.

Malar J. 2012 Sep 11;11:321. doi: 10.1186/1475-2875-11-321.

7.

Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.

Fröberg GK, Lindberg R, Ritter M, Nordlind K.

J Comp Pathol. 2009 Aug-Oct;141(2-3):89-97. doi: 10.1016/j.jcpa.2008.08.002. Epub 2009 May 15.

PMID:
19446835
8.

[Follow-up examination of schizophrenic patients with reference to their social readjustment].

Perris G, Carlsson M, Fröberg G.

Nord Psykiatr Tidsskr. 1966;20(1):3-12. Swedish. No abstract available.

PMID:
5916444

Supplemental Content

Loading ...
Support Center